Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

World’s IT Giants Target Japanese Pharmaceutical Companies In Genome Information Sharing

This article was originally published in PharmAsia News

Executive Summary

Amid major Japanese pharmaceutical companies eager to expand into overseas markets a, developing new drugs has been a top priority. In order to speed up new drug development, companies are looking for systems that allow real-time sharing of genome analysis and research information. Several IT giants market new drug development support systems specifically targeting Japanese pharmaceutical companies. British Telecom last month announced it has developed a system supporting Japanese drug makers expanding overseas. American company Cognizant partners with CTC Laboratory Systems, a subsidiary of Itochu Techno-Solutions, and will provide CTC customers with genome analysis services. IBM Japan also plans to expand sales of its system that electronically uploads and shares research notes among pharmaceutical researchers. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel